Goeltz II Robert C.

CIK 00016538813 companiesHAYWARD, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001653881

Recent Transactions

50 trades

Sale
Arcus Biosciences, Inc.$RCUS
Common Stock
2025-12-31$23.38/sh−6,552→ 67,924 total
Sale
Arcus Biosciences, Inc.$RCUS
Common Stock
2025-12-17$22.16/sh−5,960→ 74,476 total
Sale
Arcus Biosciences, Inc.$RCUS
Common Stock
2025-12-16$21.88/sh−6,702→ 80,436 total
Sale
Arcus Biosciences, Inc.$RCUS
Common Stock
2025-11-26$25.00/sh−5,000→ 87,138 total
Sale
Arcus Biosciences, Inc.$RCUS
Common Stock
2025-10-28$20.00/sh−5,000→ 92,138 total
Award
Arcus Biosciences, Inc.$RCUS
Stock Option (right to buy)
2025-01-23+150,000→ 150,000 total
Award
Arcus Biosciences, Inc.$RCUS
Common Stock
2025-01-23+37,000→ 97,138 total
Sale
Arcus Biosciences, Inc.$RCUS
Common Stock
2024-12-31$15.00/sh−3,594→ 60,138 total
Tax Payment
Arcus Biosciences, Inc.$RCUS
Common Stock
2024-12-15$16.08/sh−10,099→ 63,732 total
Award
Arcus Biosciences, Inc.$RCUS
Common Stock
2024-01-23+22,000→ 73,831 total
Award
Arcus Biosciences, Inc.$RCUS
Stock Option (right to buy)
2024-01-23+86,600→ 86,600 total
Award
Arcus Biosciences, Inc.$RCUS
Common Stock
2024-01-23+21,300→ 73,131 total
Sale
Arcus Biosciences, Inc.$RCUS
Common Stock
2024-01-02$20.00/sh−2,004→ 51,831 total
Disposition to Issuer
Arcus Biosciences, Inc.$RCUS
Common Stock
2023-12-19$18.09/sh−2,808→ 53,835 total
Disposition to Issuer
Arcus Biosciences, Inc.$RCUS
Common Stock
2023-12-18$17.74/sh−2,749→ 56,643 total
Sale
Arcus Biosciences, Inc.$RCUS
Common Stock
2023-06-07$20.04/sh−4,049→ 59,392 total
Award
Arcus Biosciences, Inc.$RCUS
Stock Option (right to buy)
2023-01-23+138,200→ 138,200 total
Award
Arcus Biosciences, Inc.$RCUS
Common Stock
2023-01-23+34,000→ 63,441 total
Sale
Arcus Biosciences, Inc.$RCUS
Common Stock
2022-12-16$30.66/sh−2,066→ 11,953 total
Sale
Arcus Biosciences, Inc.$RCUS
Common Stock
2022-12-16$31.23/sh−387→ 11,566 total
Award
Arcus Biosciences, Inc.$RCUS
Stock Option (right to buy)
2022-03-08+62,500→ 62,500 total
Award
Arcus Biosciences, Inc.$RCUS
Common Stock
2022-03-08+15,500→ 22,519 total
Sale
Arcus Biosciences, Inc.$RCUS
Common Stock
2021-12-17$38.79/sh−138→ 7,502 total
Sale
Arcus Biosciences, Inc.$RCUS
Common Stock
2021-12-17$39.67/sh−88→ 7,414 total
Sale
Arcus Biosciences, Inc.$RCUS
Common Stock
2021-12-17$40.57/sh−171→ 7,243 total
Sale
Arcus Biosciences, Inc.$RCUS
Common Stock
2021-12-17$41.42/sh−224→ 7,019 total
Sale
Arcus Biosciences, Inc.$RCUS
Common Stock
2021-12-16$39.59/sh−354→ 7,771 total
Sale
Arcus Biosciences, Inc.$RCUS
Common Stock
2021-12-16$40.46/sh−131→ 7,640 total
Award
Arcus Biosciences, Inc.$RCUS
Common Stock
2021-01-19+12,500→ 17,500 total
Award
Arcus Biosciences, Inc.$RCUS
Stock Option (right to buy)
2021-01-19+75,000→ 75,000 total
Purchase
Arcus Biosciences, Inc.$RCUS
Common Stock
2020-09-09$21.57/sh+5,000→ 5,000 total
Award
Arcus Biosciences, Inc.$RCUS
Stock Option (right to buy)
2020-08-03+250,000→ 250,000 total
Tax Payment
Unity Biotechnology, Inc.
Common Stock, $0.0001 par value
2020-06-22$9.67/sh−2,483→ 161,027 total
Award
Unity Biotechnology, Inc.
Stock Option (Right to Buy)
2020-03-30+118,188→ 118,188 total
Award
Unity Biotechnology, Inc.
Common Stock, $0.0001 par value
2020-03-30+29,106→ 163,510 total
Exercise/Conversion
Unity Biotechnology, Inc.
Common Stock, $0.0001 par value
2020-02-24$3.43/sh+10,000→ 134,404 total
Exercise/Conversion
Unity Biotechnology, Inc.
Stock Option (Right to Buy)
2020-02-24−10,000→ 110,620 total
Award
Unity Biotechnology, Inc.
Stock Option (Right to Buy)
2019-09-19+28,814→ 28,814 total
Award
Unity Biotechnology, Inc.
Stock Option (Right to Buy)
2019-06-20+116,850→ 116,850 total
Award
Unity Biotechnology, Inc.
Common Stock
2019-06-20+21,075→ 124,404 total
Exercise/Conversion
Unity Biotechnology, Inc.
Stock Option (Right to Buy)
2018-10-10−5,000→ 120,620 total
Exercise/Conversion
Unity Biotechnology, Inc.
Common Stock, $0.0001 par value
2018-10-10$3.43/sh+5,000→ 101,348 total
Conversion
Unity Biotechnology, Inc.
Series C Preferred Stock
2018-05-07−1,630→ 0 total
Conversion
Unity Biotechnology, Inc.
Common Stock
2018-05-07+1,630→ 96,348 total
Award
Unity Biotechnology, Inc.
Stock Option (Right to Buy)
2018-05-02+30,508→ 30,508 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2017-05-12−9,987→ 85,891 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2017-05-12$6.61/sh+9,987→ 32,756 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2017-05-12−9,980→ 204,678 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2017-05-12$4.47/sh+9,980→ 22,769 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2017-04-10−3,000→ 214,658 total

Companies

Recent Filings

Address

C/O ARCUS BIOSCIENCES, INC. 3928 POINT EDEN WAY

HAYWARD, CA, 94545

View on SEC.gov